Nanostics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Investors
  • 11

Nanostics General Information

Description

Operator of a precision health technology platform designed to improve early cancer detection. The company offers an AI-enabled diagnostic product that integrates machine learning with biomarker analysis, enabling partner laboratories to enhance prostate cancer screening accuracy and reduce unnecessary biopsies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4550 - 10230 Jasper Avenue. North West
  • Edmonton, Alberta T5J 4P6
  • Canada
+1 (800)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 4550 - 10230 Jasper Avenue. North West
  • Edmonton, Alberta T5J 4P6
  • Canada
+1 (800)

Nanostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) Upcoming Generating Revenue
9. Later Stage VC 17-Jul-2025 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
5. Angel (individual) Completed Generating Revenue
4. Grant 16-Jun-2022 Completed Generating Revenue
3. Angel (individual) 01-Nov-2019 Completed Clinical Trials - Phase 1
2. Angel (individual) 01-Jul-2017 $1.54M $1.54M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2017 Completed Startup
To view Nanostics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nanostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a precision health technology platform designed to improve early cancer detection. The company offers an AI-
Biotechnology
Edmonton, Canada
14 As of 2025

Liège, Belgium
 

Miami, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanostics Competitors (2)

One of Nanostics’s 2 competitors is MDxHealth, a Formerly VC-backed company based in Liège, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MDxHealth Formerly VC-backed Liège, Belgium
OPKO Health Corporation Miami, FL
You’re viewing 2 of 2 competitors. Get the full list »

Nanostics Patents

Nanostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023371553-A1 Clinical analysis and methods for predicting the risk of developing clinically significant prostate cancer Pending 04-Nov-2022
EP-4612709-A1 Clinical analysis and methods for predicting the risk of developing clinically significant prostate cancer Pending 04-Nov-2022
EP-4612709-A4 Clinical analysis and methods for predicting the risk of developing clinically significant prostate cancer Pending 04-Nov-2022
US-20260204419-A1 Clinical analysis and methods for predicting the risk of developing clinically significant prostate cancer Pending 04-Nov-2022
WO-2024092366-A1 Clinical analysis and methods for predicting the risk of developing clinically significant prostate cancer Inactive 04-Nov-2022 G16H50/20
To view Nanostics’s complete patent history, request access »

Nanostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanostics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Scale Good Fund Venture Capital Minority
Scale Up Canada Accelerator/Incubator
Copenhagen Health Innovation Accelerator/Incubator
You’re viewing 5 of 11 investors. Get the full list »

Nanostics FAQs

  • When was Nanostics founded?

    Nanostics was founded in 2017.

  • Where is Nanostics headquartered?

    Nanostics is headquartered in Edmonton, Canada.

  • What is the size of Nanostics?

    Nanostics has 14 total employees.

  • What industry is Nanostics in?

    Nanostics’s primary industry is Biotechnology.

  • Is Nanostics a private or public company?

    Nanostics is a Private company.

  • What is Nanostics’s current revenue?

    The current revenue for Nanostics is .

  • How much funding has Nanostics raised over time?

    Nanostics has raised $7.54M.

  • Who are Nanostics’s investors?

    , , Scale Good Fund, Scale Up Canada, and Copenhagen Health Innovation are 5 of 11 investors who have invested in Nanostics.

  • Who are Nanostics’s competitors?

    MDxHealth and OPKO Health are competitors of Nanostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process